Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, par value $.0001 per share
-
Shares outstanding
-
6.87M
-
Number of holders
-
67
-
Total 13F shares, excl. options
-
58.9M
-
Shares change
-
-516K
-
Total reported value, excl. options
-
$140M
-
Value change
-
-$1.22M
-
Put/Call ratio
-
0.06
-
Number of buys
-
29
-
Number of sells
-
-20
-
Price
-
$2.37
Significant Holders of Vor Biopharma Inc. - Common Stock, par value $.0001 per share (VOR) as of Q1 2024
70 filings reported holding VOR - Vor Biopharma Inc. - Common Stock, par value $.0001 per share as of Q1 2024.
Vor Biopharma Inc. - Common Stock, par value $.0001 per share (VOR) has 67 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 58.9M shares
.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (22.7M shares), FMR LLC (7.61M shares), Paradigm Biocapital Advisors LP (6.46M shares), 5AM Venture Management, LLC (6.36M shares), Laurion Capital Management LP (3.18M shares), BlackRock Inc. (2.25M shares), VANGUARD GROUP INC (1.81M shares), Woodline Partners LP (1.11M shares), JOHNSON & JOHNSON (1.07M shares), and Artal Group S.A. (1M shares).
This table shows the top 67 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.